Status:

COMPLETED

Mindfulness-Based Stress Reduction Techniques and Yoga for Treatment of Urinary Urge Incontinence (MBSR-Yoga)

Lead Sponsor:

University of Utah

Conditions:

Urinary Incontinence

Urinary Incontinence, Urge

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Many women experience the accidental loss of urine called urge incontinence or overactive bladder (OAB) incontinence. Women describe this as a sudden, strong desire to pass urine which results in leak...

Eligibility Criteria

Inclusion

  • Females at least 18 years of age
  • Five or more urge urinary incontinence episodes on a three-day voiding diary. Urge incontinence episodes will be determined based on voiding diary and subject indication of coincident urge symptoms, allowing self-characterization of incontinence type.
  • Urge predominant (urge \>50% of total incontinent episodes) urinary incontinence based on self-reported characterization of incontinent episodes on diary.
  • Request for treatment for urge urinary incontinence.
  • Subject is able to complete all study related items and interviews.

Exclusion

  • Any current or recent (past 4 weeks) anticholinergic medication use. Patient may discontinue medication and after 4 weeks may be eligible for study.
  • Past non-pharmacologic treatment for urge incontinence such as supervised behavioral therapy, supervised or unsupervised physical therapy, supervised biofeedback, and transvaginal electrical stimulation.
  • Current symptomatic urinary tract infection that has not resolved prior start of MBSR group.
  • Symptoms of pelvic organ prolapse screened by PFDI (Pelvic Floor Disorder Inventory question #3) "Do you have a bulge or something falling out that you can see or feel in the vaginal area?"
  • Previous or currently implanted neuromodulation (sacral or tibial).
  • Surgically altered detrusor muscle, such as augmentation cystoplasty.
  • Women with known neurologic disease believed to potentially affect urinary function (Multiple sclerosis, spinal cord injuries, myasthenia gravis, Charcot-Marie-Tooth disease).
  • In the opinion of the investigator, inability to understand diary instructions and complete 3-day voiding diary.
  • Subject has been previously diagnosed with interstitial cystitis or chronic pelvic pain syndrome.
  • Currently pregnant or within 6 months postpartum (pregnancy is not excluded for safety reasons but for quality of data)

Key Trial Info

Start Date :

February 1 2011

Trial Type :

INTERVENTIONAL

End Date :

February 1 2013

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01470560

Start Date

February 1 2011

End Date

February 1 2013

Last Update

December 11 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Utah

Salt Lake City, Utah, United States, 84112